Tabania, Maegladex Jeb E.

HRN: 22-49-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2023
CEFTRIAXONE 1G (VIAL)
01/19/2023
01/26/2023
IVT
3 G
24 Hrs
T/c Typhoid Ileitis, R/o Perforation
Waiting Final Action 
01/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/19/2023
01/26/2023
IVT
500 Mg
8 Hrs
T/c Typhoid Ileitis, R/o Perforation
Waiting Final Action 
01/24/2023
CIPROFLOXACIN 500MG (TAB)
01/24/2023
02/02/2023
ORAL
500
Bid
Typhoid Eleitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: